3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Thyroid Neoplasms
1
Prostatic Neoplasms
1
Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Advanced Head and Neck Carcinoma
1
Interventions
Nivolumab
14
Ipilimumab
11
Specimen Handling
9
CTLA-4 Antigen
7
pembrolizumab
6
cabozantinib
6
Magnetic Resonance Spectroscopy
6
Sunitinib
5
Axitinib
5
pazopanib
4
Biopsy
4
Radiosurgery
3
lenvatinib
2
fludarabine
2
Everolimus
2
tivozanib
1
sodium-iodide symporter
1
sitravatinib
1
belzutifan
1
atezolizumab
1
aldesleukin
1
Zoledronic Acid
1
Selenomethionine
1
Radiotherapy
1
Radiopharmaceuticals
1
Pluvicto
1
Nephrectomy
1
Metastasectomy
1
LY2510924
1
Inulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Clear-cell metastatic renal cell carcinoma
×
Radiopharmaceuticals
×
Clear all
NCT06059014
2026-04-24
PRadR
Centre Leon Berard
Phase 1/2
Completed
6 enrolled